CCR 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25878358.
- Also identified by DOI 10.1158/1078-0432.CCR-14-2552.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the August 15, 2004, issue of Clinical Cancer Research, Nielsen and colleagues demonstrated how a cancer subtype identified by gene expression profiling could be validated using a widely accessible technology (immunohistochemistry). This opened the door to large-scale studies of archival cohorts and clinical trials, which allowed detailed clinical understanding of a new genomic discovery. Clin Cancer Res; 21(8); 1779-81. ©2015 AACR. See related article by Nielsen et al., Clin Cancer Res 2004;10(16) Aug 15, 2004;5367-74.
Medical subject headings
- Breast Neoplasms
- Neoplasms, Basal Cell